Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice

Virology

Volumn 376, Issue 2, 2008, Pages 379-389

  DeDiego, Marta L ^a   Pewe, Lecia ^b   Alvarez, Enrique ^a   Rejas, Maria Teresa ^c   Perlman, Stanley ^b   Enjuanes, Luis ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b UNIVERSITY OF IOWA   (United States)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

Coronavirus; hACE 2 transgenic mice; SARS CoV

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; PROTEIN 6; PROTEIN 7A; PROTEIN 7B; PROTEIN 8A; PROTEIN 8B; PROTEIN 9B; PROTEIN E; VIRUS PROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFECTIVE VIRUS; GENE STRUCTURE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MONKEY; MORPHOGENESIS; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TRANSGENIC MOUSE; VIRION; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; CELL LINE; DNA-BINDING PROTEINS; GENE DELETION; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDYL-DIPEPTIDASE A; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TRANSCRIPTION FACTORS; VIRULENCE; VIRULENCE FACTORS;

ANIMALIA; CERCOPITHECINE HERPESVIRUS 1; CORONAVIRUS; MUS; MUS MUSCULUS; SARS CORONAVIRUS;

EID: 44649132470     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.03.005     Document Type: Article

References (75)

1. Almazan F., Galan C., and Enjuanes L. The nucleoprotein is required for efficient coronavirus genome replication. J. Virol. 78 (2004) 12683-12688
2. Almazan F., DeDiego M.L., Galan C., Escors D., Alvarez E., Ortego J., Sola I., Zuñiga S., Alonso S., Moreno J.L., Nogales A., Capiscol C., and Enjuanes L. Construction of a SARS-CoV infectious cDNA clone and a replicon to study coronavirus RNA synthesis. J. Virol. 80 (2006) 10900-10906
3. Chen C.Y., Ping Y.H., Lee H.C., Chen K.H., Lee Y.M., Chan Y.J., Lien T.C., Jap T.S., Lin C.H., Kao L.S., and Chen Y.M. Open reading frame 8a of the human severe acute respiratory syndrome coronavirus not only promotes viral replication but also induces apoptosis. J. Infect. Dis. 196 (2007) 405-415
4. Corse E., and Machamer C.E. Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles. J. Virol. 74 (2000) 4319-4326
5. Corse E., and Machamer C.E. The cytoplasmic tail of infectious bronchitis virus E protein directs Golgi targeting. J. Virol. 76 (2002) 1273-1284
6. Corse E., and Machamer C.E. The cytoplasmic tails of infectious bronchitis virus E and M proteins mediate their interaction. Virology 312 (2003) 25-34
7. de Haan C.A.M., Kuo L., Masters P.S., Vennema H., and Rottier P.J.M. Coronavirus particle assembly: primary structure requirements of the membrane protein. J. Virol. 72 (1998) 6838-6850
8. de Haan C.A.M., Masters P.S., Shen S., Weiss S., and Rottier P.J.M. The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology 296 (2002) 177-189
9. DeDiego M.L., Alvarez E., Almazan F., Rejas M.T., Lamirande E., Roberts A., Shieh W.J., Zaki S.R., Subbarao K., and Enjuanes L. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J. Virol. 81 (2007) 1701-1713
10. Devaraj S.G., Wang N., Chen Z., Chen Z., Tseng M., Barretto N., Lin R., Peters C.J., Tseng C.T., Baker S.C., and Li K. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 282 (2007) 32208-32221
11. Ding Y., He L., Zhang Q., Huang Z., Che X., Hou J., Wang H., Shen H., Qiu L., Li Z., Geng J., Cai J., Han H., Li X., Kang W., Weng D., Liang P., and Jiang S. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203 (2004) 622-630
12. Drosten C., Günther S., Preiser W., van der Werf S., Brodt H.-R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A.M., Berger A., Burguiere A.-M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.-C., Muller S., Rickerts W., Sturmer M.V.S., Klenk H.-D., and Osterhaus A.D.M.E. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348 (2003) 1967-1976
13. Emeny J.M., and Morgan M.J. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J. Gen. Virol. 43 (1979) 247-252
14. Enjuanes L., DeDiego M.L., Alvarez E., Deming D., Sheahan T., and Baric R. Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease. Virus Res. 133 (2008) 45-62
15. Enjuanes L., Gorbalenya A.E., de Groot R.J., Cowley J.A., Ziebuhr J., and Snijder E.J. The Nidovirales. In: Mahy B.W.J., Van Regenmortel M., Walker P., and Majumder-Russell D. (Eds). "Encyclopedia of Virology. Third Edition (2008), Elsevier Ltd., Oxford.
16. Fischer F., Stegen C.F., Masters P.S., and Samsonoff W.A. Analysis of constructed E gene mutants of mouse hepatitis virus confirms a pivotal role for E protein in coronavirus assembly. J. Virol. 72 (1998) 7885-7894
17. Fouchier R.A., Kuiken T., Schutten M., van Amerongen G., van Doornum G.J., van den Hoogen B.G., Peiris M., Lim W., Stohr K., and Osterhaus A.D. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423 (2003) 240
18. Fouchier R.A., Hartwig N.G., Bestebroer T.M., Niemeyer B., de Jong J.C., Simon J.H., and Osterhaus A.D. A previously undescribed coronavirus associated with respiratory disease in humans. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 6212621-6212626
19. Frieman M., Yount B., Heise M., Kopecky-Bromberg S.A., Palese P., and Baric R.S. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J. Virol. 81 (2007) 9812-9824
20. Gillim-Ross L., Taylor J., Scholl D.R., Ridenour J., Masters P.S., and Wentworth D.E. Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR. J. Clin. Microbiol. 42 (2004) 3196-3206
21. Gorbalenya A.E., Snijder E.J., and Spaan W.J. Severe acute respiratory syndrome coronavirus phylogeny: toward consensus. J. Virol. 78 (2004) 7863-7866
22. Gu J., Gong E., Zhang B., Zheng J., Gao Z., Zhong Y., Zou W., Zhan J., Wang S., Xie Z., Zhuang H., Wu B., Zhong H., Shao H., Fang W., Gao D., Pei F., Li X., He Z., Xu D., Shi X., Anderson V.M., and Leong A.S. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 202 (2005) 415-424
23. Guan Y., Zheng B.J., He Y.Q., Liu X.L., Zhuang Z.X., Cheung C.L., Luo S.W., Li P.H., Zhang L.J., Guan Y.J., Butt K.M., Wong K.L., Chan K.W., Lim W., Shortridge K.F., Yuen K.Y., Peiris J.S., and Poon L.L. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302 (2003) 276-278
24. Haijema B.J., Volders H., and Rottier P.J. Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J. Virol. 78 (2004) 3863-3871
25. Hattermann K., Muller M.A., Nitsche A., Wendt S., Donoso Mantke O., and Niedrig M. Susceptibility of different eukaryotic cell lines to SARS-coronavirus. Arch. Virol. 150 (2005) 1023-1031
26. Huang C., Ito N., Tseng C.T., and Makino S. Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein. J. Virol. 80 (2006) 7287-7294
27. Huang C., Peters C.J., and Makino S. Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells. J. Virol. 81 (2007) 5423-5426
28. Ito N., Mossel E.C., Narayanan K., Popov V.L., Huang C., Inoue T., Peters C.J., and Makino S. Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein. J. Virol. 79 (2005) 3182-3186
29. Kaiser L., Regamey N., Roiha H., Deffernez C., and Frey U. Human coronavirus NL63 associated with lower respiratory tract symptoms in early life. Pediatr. Infect. Dis. J. 24 (2005) 1015-1017
30. Khan S., Fielding B.C., Tan T.H., Chou C.F., Shen S., Lim S.G., Hong W., and Tan Y.J. Over-expression of severe acute respiratory syndrome coronavirus 3b protein induces both apoptosis and necrosis in Vero E6 cells. Virus Res. 122 (2006) 20-27
31. Kong W.P., Xu L., Stadler K., Ulmer J.B., Abrignani S., Rappuoli R., and Nabel G.J. Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization. J. Virol. 79 (2005) 13915-13923
32. Kopecky-Bromberg S.A., Martinez-Sobrido L., Frieman M., Baric R.A., and Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 81 (2007) 548-557
33. Ksiazek T.G., Erdman D., Goldsmith C., Zaki S., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S., Ling A.-E., Humphrey C., Shieh W.-J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J.-Y., Cox N., Hughes J., LeDuc J.W., Bellini W.J., and Anderson L.J. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348 (2003) 1953-1966
34. Kuiken T., Fouchier R.A.M., Schutten M., Rimmelzwaan G.F., van Amerongen G., van Riel D., Laman J.D., de Jong T., van Doornum G., Lim W., Ling A.E., Chan P.K.S., Tam J.S., Zambon M.C., Gopal R., Drosten C., van der Werf S., Escriou N., Manuguerra J.-C., Stohr K., and Peiris J.S.M. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362 (2003) 263-270
35. Kuo L., and Masters P.S. The small envelope protein E is not essential for murine coronavirus replication. J. Virol. 77 (2003) 4597-4608
36. Lai C.W., Chan Z.R., Yang D.G., Lo W.H., Lai Y.K., Chang M.D., and Hu Y.C. Accelerated induction of apoptosis in insect cells by baculovirus-expressed SARS-CoV membrane protein. FEBS Lett. 580 (2006) 3829-3834
37. Lau S.K., Woo P.C., Li K.S., Huang Y., Tsoi H.W., Wong B.H., Wong S.S., Leung S.Y., Chan K.H., and Yuen K.Y. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14040-14045
38. Law P.T., Wong C.H., Au T.C., Chuck C.P., Kong S.K., Chan P.K., To K.F., Lo A.W., Chan J.Y., Suen Y.K., Chan H.Y., Fung K.P., Waye M.M., Sung J.J., Lo Y.M., and Tsui S.K. The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells. J. Gen. Virol. 86 (2005) 1921-1930
39. Lee D.T., Wing Y.K., Leung H.C., Sung J.J., Ng Y.K., Yiu G.C., Chen R.Y., and Chiu H.F. Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study. Clin. Infect. Dis. 39 (2004) 1247-1249
40. Li W., Shi Z., Yu M., Ren W., Smith C., Epstein J.H., Wang H., Crameri G., Hu Z., Zhang H., Zhang J., McEachern J., Field H., Daszak P., Eaton B.T., Zhang S., and Wang L.F. Bats are natural reservoirs of SARS-like coronaviruses. Science 310 (2005) 676-679
41. Marra M.A., Jones S.J.M., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S.N., Khattra J., Asano J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C., and Roper R.L. The genome sequence of the SARS-associated coronavirus. Science 300 (2003) 1399-1404
42. McCray Jr. P.B., Pewe L., Wohlford-Lenane C., Hickey M., Manzel L., Shi L., Netland J., Jia H.P., Halabi C., Sigmund C.D., Meyerholz D.K., Kirby P., Look D.C., and Perlman S. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 81 (2007) 813-821
43. Meier C., Aricescu A.R., Assenberg R., Aplin R.T., Gilbert R.J., Grimes J.M., and Stuart D.I. The crystal structure of ORF-9b, a lipid binding protein from the SARS coronavirus. Structure 14 (2006) 1157-1165
44. Mossel E.C., Huang C., Narayanan K., Makino S., Tesh R.B., and Peters C.J. Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication. J. Virol. 79 (2005) 3846-3850
45. Nelson C.A., Pekosz A., Lee C.A., Diamond M.S., and Fremont D.H. Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein. Structure 13 (2005) 75-85
46. Ng M.L., Tan S.H., See E.E., Ooi E.E., and Ling A.E. Proliferative growth of SARS coronavirus in Vero E6 cells. J. Gen. Virol. 84 (2003) 3291-3303
47. Ontiveros E., Kuo L., Masters P.S., and Perlman S. Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS. Virology 289 (2001) 230-238
48. Ortego J., Sola I., Almazan F., Ceriani J.E., Riquelme C., Balasch M., Plana-Durán J., and Enjuanes L. Transmissible gastroenteritis coronavirus gene 7 is not essential but influences in vivo virus replication and virulence. Virology 308 (2003) 13-22
49. Peiris J.S.M., Lai S.T., Poon L.L.M., Guan Y., Yam L.Y.C., Lim W., Nicholls J., Yee W.K.S., Yan W.W., and Cheung M.T. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361 (2003) 1319-1325
50. Pewe L., Zhou H., Netland J., Tangudu C., Olivares H., Shi L., Look D., Gallagher T., and Perlman S. A severe acute respiratory syndrome-associated coronavirus-specific protein enhances virulence of an attenuated murine coronavirus. J. Virol. 79 (2005) 11335-11342
51. Qin E., Shi H., Tang L., Wang C., Chang G., Ding Z., Zhao K., Wang J., Chen Z., Yu M., Si B., Liu J., Wu D., Cheng X., Yang B., Peng W., Meng Q., Liu B., Han W., Yin X., Duan H., Zhan D., Tian L., Li S., Wu J., Tan G., Li Y., Liu Y., Liu H., Lv F., Zhang Y., Kong X., Fan B., Jiang T., Xu S., Wang X., Li C., Wu X., Deng Y., Zhao M., and Zhu Q. Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine. Vaccine 24 (2006) 1028-1034
52. Qu D., Zheng B., Yao X., Guan Y., Yuan Z.H., Zhong N.S., Lu L.W., Xie J.P., and Wen Y.M. Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice. Vaccine 23 (2005) 924-931
53. Roberts A., Deming D., Paddock C.D., Cheng A., Yount B., Vogel L., Herman B.D., Sheahan T., Heise M., Genrich G.L., Zaki S.R., Baric R., and Subbarao K. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog. 3 (2007) 23-37
54. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campganoli R., Icenogle J.P., Peñaranda S., Bankamp B., Maher K., Chen M.-H., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdman D.d., Peret T.C.T., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rassmussen M., Fouchier R., Gunther S., Osterhaus A.D.M.E., Drosten C., Pallansch M.A., Anderson L.J., and Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300 (2003) 1394-1399
55. Sanchez C.M., Izeta A., Sánchez-Morgado J.M., Alonso S., Sola I., Balasch M., Plana-Duran J., and Enjuanes L. Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence. J. Virol. 73 (1999) 7607-7618
56. Schaecher S.R., Mackenzie J.M., and Pekosz A. The ORF7b protein of SARS-CoV is expressed in virus-infected cells and incorporated into SARS-CoV particles. J. Virol. 81 (2007) 718-731
57. Shen S., Lin P.S., Chao Y.C., Zhang A., Yang X., Lim S.G., Hong W., and Tan Y.J. The severe acute respiratory syndrome coronavirus 3a is a novel structural protein. Biochem. Biophys. Res. Commun. 330 (2005) 286-292
58. Sims A.C., Burkett S.E., Yount B., and Pickles R.J. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium. Virus Res. 133 (2008) 33-44
59. Snijder E.J., Bredenbeek P.J., Dobbe J.C., Thiel V., Ziebuhr J., Poon L.L.M., Guan Y., Rozanov M., Spaan W.J.M., and Gorbalenya A.E. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331 (2003) 991-1004
60. Spruth M., Kistner O., Savidis-Dacho H., Hitter E., Crowe B., Gerencer M., Bruhl P., Grillberger L., Reiter M., Tauer C., Mundt W., and Barrett P.N. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses. Vaccine 24 (2006) 652-661
61. Subbarao K., and Roberts A. Is there an ideal animal model for SARS?. Trends Microbiol. 14 (2006) 299-303
62. Sutter R.W., Kew O.M., and Cochi S.M. Poliovirus vaccine-Live. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. (2004), Elsevier, Philadelphia 651-705
63. Tan Y.X., Tan T.H., Lee M.J., Tham P.Y., Gunalan V., Druce J., Birch C., Catton M., Fu N.Y., Yu V.C., and Tan Y.J. Induction of apoptosis by the severe acute respiratory syndrome coronavirus 7a protein is dependent on its interaction with the Bcl-xl protein. J. Virol. 81 (2007) 6346-6355
64. Tangudu C., Olivares H., Netland J., Perlman S., and Gallagher T. Severe acute respiratory syndrome coronavirus protein 6 accelerates murine coronavirus infections. J. Virol. 81 (2007) 1220-1229
65. Thiel V., Ivanov K.A., Putics A., Hertzig T., Schelle B., Bayer S., Wessbrich B., Snijder E.J., Rabenau H., Doerr H.W., Gorbalenya A.E., and Ziebuhr J. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84 (2003) 2305-2315
66. Tseng C.T., Huang C., Newman P., Wang N., Narayanan K., Watts D.M., Makino S., Packard M.M., Zaki S.R., Chan T.S., and Peters C.J. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor. J. Virol. 81 (2007) 1162-1173
67. van der Hoek L., Pyrc K., Jebbink M.F., Vermeulen-Oost W., Berkhout R.J., Wolthers K.C., Wertheim-van Dillen P.M., Kaandorp J., Spaargaren J., and Berkhout B. Identification of a new human coronavirus. Nat. Med. 10 (2004) 368-373
68. Wathelet M.G., Orr M., Frieman M.B., and Baric R.S. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J. Virol. 81 (2007) 11620-11633
69. Weiss S.R., and Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 69 (2005) 635-664
70. Woo P.C., Lau S.K., Chu C.M., Chan K.H., Tsoi H.W., Huang Y., Wong B.H., Poon R.W., Cai J.J., Luk W.K., Poon L.L., Wong S.S., Guan Y., Peiris J.S., and Yuen K.Y. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol. 79 (2005) 884-895
71. Xu J., Zhong S., Liu J., Li L., Li Y., Wu X., Li Z., Deng P., Zhang J., Zhong N., Ding Y., and Jiang Y. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin. Infect. Dis. 41 (2005) 1089-1096
72. Yang Y., Xiong Z., Zhang S., Yan Y., Nguyen J., Ng B., Lu H., Brendese J., Yang F., Wang H., and Yang X.F. Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors. Biochem. J. 392 (2005) 135-143
73. Yount B., Roberts R.S., Sims A.C., Deming D., Frieman M.B., Sparks J., Denison M.R., Davis N., and Baric R.S. Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice. J. Virol. 79 (2005) 14909-14922
74. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9294-9299
75. Zhou J., Wang W., Zhong Q., Hou W., Yang Z., Xiao S.Y., Zhu R., Tang Z., Wang Y., Xian Q., Tang H., and Wen L. Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys. Vaccine 23 (2005) 3202-3209